Files
20250920-e194e889/analysis_reports/detailed/RVPH_detailed_20250920_015345.json
2026-04-25 19:21:28 +08:00

112 lines
2.7 KiB
JSON

{
"analysis_metadata": {
"symbol": "RVPH",
"analysis_date": "2025-09-20T01:53:45.875995",
"timestamp": "20250920_015345",
"version": "1.0"
},
"company_info": {
"name": "Reviva Pharmaceuticals Holdings, Inc.",
"symbol": "RVPH",
"industry": "Biotechnology",
"sector": "Healthcare",
"market_cap": 17710000,
"employees": 14,
"website": "https://www.revivapharma.com",
"country": "United States",
"currency": "USD"
},
"financial_data": {
"revenue": 0,
"net_income": -29100000,
"total_assets": 15500000,
"total_liabilities": 14690000,
"cash": 1020000,
"debt": 0
},
"valuation_analysis": {
"pe_ratio": null,
"pb_ratio": null,
"ps_ratio": null,
"peg_ratio": null,
"market_cap": 17710000,
"enterprise_value": 7460000,
"valuation_score": 15,
"is_undervalued": false
},
"financial_health": {
"current_ratio": 0.9,
"quick_ratio": 0.9,
"debt_to_equity": null,
"debt_ratio": 0.95,
"roe": -9.16,
"roa": -2.75,
"profit_margin": null,
"operating_margin": null,
"health_score": 10,
"is_healthy": false
},
"growth_analysis": {
"revenue_growth": 0,
"earnings_growth": 0,
"historical_growth": 0,
"growth_score": 5,
"is_growing": false
},
"risk_analysis": {
"beta": -0.06,
"volatility": 0.894,
"max_drawdown": 0.93,
"risk_score": 20,
"risk_level": "极高"
},
"investment_recommendation": {
"recommendation": "观望/高风险投机",
"confidence": "高",
"overall_score": 35,
"risk_warnings": [
"极高风险投资",
"财务健康度极差",
"无收入来源",
"持续亏损",
"依赖融资维持运营",
"监管审批不确定性",
"可能完全损失本金"
],
"key_strengths": [
"专注精神分裂症治疗",
"主要产品临床试验积极",
"分析师全部给予买入评级",
"获得FDA对齐"
],
"key_concerns": [
"无商业化产品",
"持续亏损",
"高债务比率",
"股价大幅下跌",
"流动性风险"
]
},
"analyst_opinions": {
"total_analysts": 13,
"buy_ratings": 13,
"hold_ratings": 0,
"sell_ratings": 0,
"average_target_price": 14.46,
"price_target_range": "2.00 - 20.00"
},
"market_data": {
"current_price": 0.26,
"previous_close": 0.42,
"day_change": -0.16,
"day_change_percent": -37.89,
"volume": 29973974,
"avg_volume": 2720000,
"market_cap": 17710000,
"shares_outstanding": 68000000,
"float": 60810000,
"insider_ownership": 10.59,
"institutional_ownership": 21.25
},
"raw_data": {}
}